BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063
552 results:

  • 1. Artesunate attenuates the tumorigenesis of choroidal melanoma via inhibiting EFNA3 through stat3/Akt signaling pathway.
    Yao N; Ma Q; Yi W; Zhu Y; Liu Y; Gao X; Zhang Q; Luo W
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):202. PubMed ID: 38630320
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Inhibiting IL11RA to mitigate hepatic metastasis in skin cutaneous melanoma: Comprehensive insights from in vitro and in vivo investigations.
    Zhang ZG; Zhu HM; Hua HK
    Skin Res Technol; 2024 Mar; 30(3):e13618. PubMed ID: 38468436
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Effects of extracellular vesicles from adipose-derived stem cells on human keloid fibroblasts via the SOCS1/JAK2/stat3 pathway.
    Ruan H; Wang J; Shi H; Luan W
    J Cosmet Dermatol; 2024 Apr; 23(4):1404-1416. PubMed ID: 38288516
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Uncovering the Anti-Angiogenic Mechanisms of
    Zhao B; Li Y; Wang B; Liu J; Yang Y; Quan Q; An Q; Liang R; Liu C; Yang C
    Molecules; 2024 Jan; 29(2):. PubMed ID: 38257275
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Radix Tetrastigma Hemsleyani Flavone represses cutaneous squamous cell carcinoma via Janus kinase/signal transducer and activator of transcription 3 pathway inactivation.
    Peng J; Luo X; Wang T; Yue C; Duan M; Wu C
    Cytokine; 2024 Mar; 175():156480. PubMed ID: 38232644
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The predictive efficacy of programmed cell death in immunotherapy of melanoma: A comprehensive analysis of gene expression data for programmed cell death biomarker and therapeutic target discovery.
    Yue C; Lian W; Duan M; Xia D; Cao X; Peng J
    Environ Toxicol; 2024 Mar; 39(3):1858-1873. PubMed ID: 38140739
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Targeting Fatty Acid Amide Hydrolase Counteracts the Epithelial-to-Mesenchymal Transition in Keratinocyte-Derived Tumors.
    Kovacs D; Flori E; Bastonini E; Mosca S; Migliano E; Cota C; Zaccarini M; Briganti S; Cardinali G
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139209
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Primary cutaneous CD30+ lymphoproliferative disorders with DUSP22 translocation.
    Montes-Moreno S
    Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):136-139. PubMed ID: 38010388
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Protopanaxatriol activates EGFR and HER2 to strengthen the molecules of skin protection in human keratinocytes.
    You L; Shen T; Hu W; Cho JY
    Phytomedicine; 2024 Jan; 123():155167. PubMed ID: 37952408
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. KIF22 promotes the proliferation and glycolysis of melanoma by activating EGFR/stat3 signaling.
    Zhong Z; Zhong H
    Clinics (Sao Paulo); 2023; 78():100307. PubMed ID: 37944197
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Synthesis and characterization of piperic acid conjugates with homochiral and heterochiral dipeptides containing phenylalanine and their application in skin cancer.
    Ur Rahim J; Faheem MM; Nawaz S; Goswami A; Rai R
    Peptides; 2023 Dec; 170():171113. PubMed ID: 37923167
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A systematic review regarding the prevalence of malignancy in patients with the hyper-IgE syndrome.
    Mohammadi T; Azizi G; Rafiemanesh H; Farahani P; Nirouei M; Tavakol M
    Clin Exp Med; 2023 Dec; 23(8):4835-4859. PubMed ID: 37924455
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
    Sohel M
    Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. In Vitro Experiments on the Effects of GP-2250 on BRAF-Mutated Melanoma Cell Lines and Benign Melanocytes.
    Gambichler T; Harnischfeger F; Skrygan M; Majchrzak-Stiller B; Buchholz M; Müller T; Braumann C
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895015
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. What Is New in Cutaneous T Cell Lymphoma?
    Morgenroth S; Roggo A; Pawlik L; Dummer R; Ramelyte E
    Curr Oncol Rep; 2023 Nov; 25(11):1397-1408. PubMed ID: 37874473
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Bufotalin Suppresses Proliferation and Metastasis of Triple-Negative Breast cancer Cells by Promoting Apoptosis and Inhibiting the stat3/EMT Axis.
    Park SJ; Jung HJ
    Molecules; 2023 Sep; 28(19):. PubMed ID: 37836626
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. ANXA1 Promotes Tumor Immune Evasion by Binding PARP1 and Upregulating stat3-Induced Expression of PD-L1 in Multiple cancers.
    Xiao D; Zeng T; Zhu W; Yu ZZ; Huang W; Yi H; Lu SS; Feng J; Feng XP; Wu D; Wen Q; Zhou JH; Yuan L; Zhuang W; Xiao ZQ
    Cancer Immunol Res; 2023 Oct; 11(10):1367-1383. PubMed ID: 37566399
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The impact of cellular elements of TME on melanoma biology and its sensitivity to EGFR and MET targeted therapy.
    Wądzyńska J; Simiczyjew A; Pietraszek-Gremplewicz K; Kot M; Ziętek M; Matkowski R; Nowak D
    Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119549. PubMed ID: 37506884
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Melanoma cells induce dedifferentiation and metabolic changes in adipocytes present in the tumor niche.
    Simiczyjew A; Wądzyńska J; Pietraszek-Gremplewicz K; Kot M; Ziętek M; Matkowski R; Nowak D
    Cell Mol Biol Lett; 2023 Jul; 28(1):58. PubMed ID: 37481560
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. cancer-associated fibroblasts promote cancer stemness by inducing expression of the chromatin-modifying protein CBX4 in squamous cell carcinoma.
    Fisher ML; Balinth S; Hwangbo Y; Wu C; Ballon C; Goldberg GL; Mills AA
    Carcinogenesis; 2023 Aug; 44(6):485-496. PubMed ID: 37463322
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 28.